Document Type

Article

Publication Date

Spring 2022

Abstract

Engineering T cells with a chimeric antigen receptor (CAR) recognizing proteins specifically expressed on tumor cells is a new cancer therapy. While CAR T cells can successfully treat hematopoietic malignancies, CAR T cells have not shown success in treating solid tumors. In addition, one side effect observed after CAR T cell infusion is Cytokine Release Syndrome (CRS) which causes damaging inflammation. There are many factors that may enhance CAR T cell efficacy and safety for solid tumor treatment, including costimulatory domains to increase T cell functions and switching T cell type from alpha beta to gamma delta T cells. We developed a novel CAR (chimeric PD-1, chPD1) that targets the programmed death 1 receptor (PD-1) ligands expressed on many types of solid tumors. The aim of this study was to compare anti-tumor efficacy and CRS induction between chPD1-expressing gamma delta and alpha beta T cells in murine breast cancer models. Inclusion of different costimulatory domains, CD28, 4-1BB, and Dap-10, in the chPD1 receptor was also compared. There were no differences in T cell viability and proliferation when comparing costimulatory domains or T cell type. Additionally, there were no significant differences in killing of murine 4T-1 and E077 breast cancer cells. ChPD1-CD28 T cells had increased secretion of proinflammatory and CRS-inducing cytokines and chemokines, including IFN-gamma, IL-2, and nitric oxide, compared to chPD1-41BB and chPD1-Dap10 receptors. Overall, alpha beta chPD1 T cells also had increased cytokine secretion compared to chPD1 gamma delta T cells. Therefore, inclusion of 4-1BB or Dap10 domains in gamma delta T cells may be a safer and more efficacious option for CAR T cell therapy of solid tumors.

Comments

Faculty Advisor: Dr. Amorette Barber

Committee Members: Dr. Brandon Jackson (Longwood University), Dr. Erin Shanle (Longwood University), and Dr. James Cripps (University of Louisville).

Included in

Biology Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.